BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27352189)

  • 21. Inflammatory bowel disease, gut bacteria and probiotic therapy.
    Reiff C; Kelly D
    Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Subramanian V; Logan RF
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):593-606. PubMed ID: 22122774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer.
    Francescangeli F; De Angelis ML; Zeuner A
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31816977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Tambuwala MM
    Inflamm Bowel Dis; 2016 Mar; 22(3):719-23. PubMed ID: 26717321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of dietary polyphenols in the moderation of the inflammatory response in early stage colorectal cancer.
    Little CH; Combet E; McMillan DC; Horgan PG; Roxburgh CS
    Crit Rev Food Sci Nutr; 2017 Jul; 57(11):2310-2320. PubMed ID: 26066365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-inflammatory effects of Brazilian ginseng (Pfaffia paniculata) on TNBS-induced intestinal inflammation: Experimental evidence.
    Costa CA; Tanimoto A; Quaglio AE; Almeida LD; Severi JA; Di Stasi LC
    Int Immunopharmacol; 2015 Sep; 28(1):459-69. PubMed ID: 26202807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phytochemicals - A Novel and Prominent Source of Anti-cancer Drugs Against Colorectal Cancer.
    Mahadevappa R; Kwok HF
    Comb Chem High Throughput Screen; 2017; 20(5):376-394. PubMed ID: 28078982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response.
    Sánchez-Alcoholado L; Ramos-Molina B; Otero A; Laborda-Illanes A; Ordóñez R; Medina JA; Gómez-Millán J; Queipo-Ortuño MI
    Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32486066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease.
    Nie Y; Lin Q; Luo F
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28654020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toxicological Evaluation of a Probiotic-Based Delivery System for P8 Protein as an Anti-Colorectal Cancer Drug.
    An BC; Yoon YS; Park HJ; Park S; Kim TY; Ahn JY; Kwon D; Choi O; Heo JY; Ryu Y; Kim JH; Eom H; Chung MJ
    Drug Des Devel Ther; 2021; 15():4761-4793. PubMed ID: 34866901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation and disease duration have a cumulative effect on the risk of dysplasia and carcinoma in IBD: a case-control observational study based on registry data.
    Nieminen U; Jussila A; Nordling S; Mustonen H; Färkkilä MA
    Int J Cancer; 2014 Jan; 134(1):189-96. PubMed ID: 23797639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contentious host-microbiota relationship in inflammatory bowel disease--can foes become friends again?
    Satokari R
    Scand J Gastroenterol; 2015 Jan; 50(1):34-42. PubMed ID: 25523554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A mechanistic review on plant-derived natural compounds as dietary supplements for prevention of inflammatory bowel disease.
    Farzaei MH; Bahramsoltani R; Abdolghaffari AH; Sodagari HR; Esfahani SA; Rezaei N
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):745-58. PubMed ID: 26799847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ellagitannins, Gallotannins and their Metabolites- The Contribution to the Anti-Inflammatory Effect of Food Products and Medicinal Plants.
    Kiss AK; Piwowarski JP
    Curr Med Chem; 2018; 25(37):4946-4967. PubMed ID: 27655073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of gastrointestinal cancer--the potential role of NSAIDs in colorectal cancer.
    Luk GD
    Schweiz Med Wochenschr; 1996 May; 126(19):801-12. PubMed ID: 8693304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut microbiota: An emerging therapeutic approach of herbal medicine for prevention of colorectal cancer.
    Ying HZ; Xie W; Wang MC; He JQ; Zhang HH; Yu CH
    Front Cell Infect Microbiol; 2022; 12():969526. PubMed ID: 36051242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of calcium supplementation on biomarkers of inflammation and oxidative stress in colorectal adenoma patients: a randomized controlled trial.
    Yang B; Gross MD; Fedirko V; McCullough ML; Bostick RM
    Cancer Prev Res (Phila); 2015 Nov; 8(11):1069-75. PubMed ID: 26304464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.